Literature DB >> 24879553

Intraarticular platelet-rich plasma injection in the treatment of knee osteoarthritis: review and recommendations.

Adam M Pourcho1, Jay Smith, Stephen J Wisniewski, Jacob L Sellon.   

Abstract

Intraarticular platelet-rich plasma (PRP) injection has emerged as a promising treatment for knee osteoarthritis. Studies to date, including multiple randomized controlled trials, have shown that PRP is a safe and effective treatment option for knee osteoarthritis. Intraarticular PRP is similar in efficacy to hyaluronic acid, and seems to be more effective than hyaluronic acid in younger, active patients with low-grade osteoarthritis. Treatment benefits seem to wane after 6-9 mos. There are numerous PRP treatment variables that may be of importance, and the optimal PRP protocol remains unclear. Future investigations should control and analyze the effects of these variables in PRP treatment. High-quality randomized controlled trials are needed to optimize PRP treatment methods and better define the role of PRP in osteoarthritis management in the knee and, potentially, in other joints.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24879553     DOI: 10.1097/PHM.0000000000000115

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  15 in total

1.  Decrease of serum biomarker of type II Collagen degradation (Coll2-1) by intra-articular injection of an autologous plasma-rich-platelet in patients with unilateral primary knee osteoarthritis.

Authors:  Rasha Mohamed Fawzy; Nashwa Ismail Hashaad; Amira Ibrahim Mansour
Journal:  Eur J Rheumatol       Date:  2017-06-01

Review 2.  [Osteoarthritis: what internists should know].

Authors:  L Wildi
Journal:  Internist (Berl)       Date:  2015-05       Impact factor: 0.743

3.  Hyaluronic acid in the management of osteoarthritis: injection therapies innovations.

Authors:  Valter Santilli; Marco Paoloni; Massimiliano Mangone; Federica Alviti; Andrea Bernetti
Journal:  Clin Cases Miner Bone Metab       Date:  2016-10-05

Review 4.  Effectiveness of intra-articular therapies in osteoarthritis: a literature review.

Authors:  Peter Wehling; Christopher Evans; Jana Wehling; William Maixner
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-06-20       Impact factor: 5.346

Review 5.  Biologic Therapy in Chronic Pain Management: a Review of the Clinical Data and Future Investigations.

Authors:  Mark Whitney Motejunas; Lauren Bonneval; Cleo Carter; Devin Reed; Ken Ehrhardt
Journal:  Curr Pain Headache Rep       Date:  2021-03-24

6.  Clinical comparison of platelet-rich plasma injection and daily celecoxib administration in the treatment of early knee osteoarthritis: A randomized clinical trial.

Authors:  Ruben Reyes-Sosa; Agustin Lugo-Radillo; Lizzet Cruz-Santiago; Celia Rubi Garcia-Cruz; Oliver Mendoza-Cano
Journal:  J Appl Biomed       Date:  2020-08-20       Impact factor: 1.797

7.  Role of Triple Injection Platelet-Rich Plasma for Osteoarthritis Knees: A 2 Years Follow-Up Study.

Authors:  Najmul Huda; Mir Shahid Ul Islam; Sandeep Bishnoi; Hemant Kumar; Shubham Aggarwal; Aijaz Ahmad Ganai
Journal:  Indian J Orthop       Date:  2021-07-29       Impact factor: 1.033

Review 8.  PRP and articular cartilage: a clinical update.

Authors:  Antonio Marmotti; Roberto Rossi; Filippo Castoldi; Eliana Roveda; Gianni Michielon; Giuseppe M Peretti
Journal:  Biomed Res Int       Date:  2015-05-05       Impact factor: 3.411

9.  A dose response analysis of a specific bone marrow concentrate treatment protocol for knee osteoarthritis.

Authors:  Christopher J Centeno; Hasan Al-Sayegh; Jamil Bashir; Shaun Goodyear; Michael D Freeman
Journal:  BMC Musculoskelet Disord       Date:  2015-09-18       Impact factor: 2.362

10.  Clinical effectiveness in severe knee osteoarthritis after intra-articular platelet-rich plasma therapy in association with hyaluronic acid injection: three case reports.

Authors:  Szu-Hsuan Chen; Ta-Shen Kuan; Mu-Jung Kao; Wei-Ting Wu; Li-Wei Chou
Journal:  Clin Interv Aging       Date:  2016-09-08       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.